Stacie Lindsey, CEO at Cholangiocarcinoma Foundation, shared a post on LinkedIn:
“It was a pleasure to be at Houston Methodist with CCF and our partners for the Houston Regional Symposium.
Attendees connected to those facing similar circumstances, learned from the experts, shared their stories, and received information on new resources.
These events are critical for those in the rare cancer space, so they can share lived experiences and stay current with what is available in treatments and support.
Thank you to Houston Methodist, MD Anderson Cancer Center, AstraZeneca, Incyte, Jazz Pharmaceuticals, Merck, Natera, Partner Therapeutics, and Servier for helping make this event possible through collaboration and support.”
More posts featuring Stacie Lindsey.
